SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-060673
Filing Date
2023-11-08
Accepted
2023-11-08 07:10:15
Documents
14
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgem-20231108.htm   iXBRL 8-K 47176
2 EX-99.1 cgem-ex99_1.htm EX-99.1 247174
3 GRAPHIC img184014297_0.jpg GRAPHIC 60322
  Complete submission text file 0000950170-23-060673.txt   512067

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20231108.xsd EX-101.SCH 2493
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20231108_lab.xml EX-101.LAB 13904
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20231108_pre.xml EX-101.PRE 10246
8 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20231108_htm.xml XML 4885
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 231385939
SIC: 2836 Biological Products, (No Diagnostic Substances)